Related Experiment Video
Updated: Nov 21, 2025
Getting to Compliance in Forced Exercise in Rodents: A Critical Standard to Evaluate Exercise Impact in Aging-related Disorders and Disease
Published on: August 22, 2014
Oxidopamine and oxidative stress: Recent advances in experimental physiology and pharmacology
Igor Pantic1, Jelena Cumic2, Sanja Radojevic Skodric3
1University of Belgrade, Faculty of Medicine, Dr Subotica 8, RS-11129, Belgrade, Serbia; University of Haifa, 199 Abba Hushi Blvd, Mount Carmel, Haifa, IL-3498838, Israel; Institute of medical physiology, Visegradska 26/II, RS-11129, Belgrade, Serbia.
Abstract:
Oxidopamine (6-hydroxydopamine, 6-OHDA) is a toxin commonly used for the creation of experimental animal models of Parkinson's disease, attention-deficit hyperactivity disorder, and Lesch-Nyhan syndrome. Its exact mechanism of action is not completely understood, although there are many indications that it is related to the generation of reactive oxygen species (ROS), primarily in dopaminergic neurons. In certain experimental conditions, oxidopamine may also cause programmed cell death via various signaling pathways. Oxidopamine may also have a significant impact on chromatin structure and nuclear structural organization in some cells. Today, many researchers use oxidopamine-associated oxidative damage to evaluate different antioxidant-based pharmacologically active compounds as drug candidates for various neurological and non-neurological diseases. Additional research is needed to clarify the exact biochemical pathways associated with oxidopamine toxicity, related ROS generation and apoptosis. In this short review, we focus on the recent research in experimental physiology and pharmacology, related to the cellular and animal experimental models of oxidopamine - mediated toxicity.
Insights
Oxidopamine (6-hydroxydopamine, 6-OHDA) is a neurotoxin used in research models. Its toxicity mechanisms, involving reactive oxygen species and apoptosis, are explored for developing new antioxidant therapies.
Area of Science:
- Neuroscience
- Pharmacology
- Toxicology
Background:
- Oxidopamine (6-hydroxydopamine, 6-OHDA) is a widely used neurotoxin.
- It serves as a critical tool in creating experimental models for Parkinson's disease, ADHD, and Lesch-Nyhan syndrome.
- The precise mechanisms underlying oxidopamine's neurotoxicity are still under investigation.
Purpose of the Study:
- To review recent research on oxidopamine-mediated toxicity.
- To highlight its role in experimental physiology and pharmacology.
- To focus on cellular and animal models of oxidopamine toxicity.
Main Methods:
- Review of current scientific literature on oxidopamine.
- Analysis of experimental data from cellular and animal models.
- Focus on biochemical pathways and oxidative stress mechanisms.
Main Results:
- Oxidopamine toxicity is strongly linked to the generation of reactive oxygen species (ROS), particularly in dopaminergic neurons.
- It can induce programmed cell death (apoptosis) through various signaling pathways.
- Oxidopamine impacts chromatin structure and nuclear organization.
Conclusions:
- Oxidopamine-induced oxidative damage is a key area for evaluating antioxidant compounds.
- Further research is essential to fully elucidate the biochemical pathways of oxidopamine toxicity, ROS generation, and apoptosis.
- Understanding these mechanisms is crucial for developing novel therapeutic strategies for neurological and non-neurological diseases.
Related Concept Videos
01:26Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
01:29Drugs Affecting Neurotransmitter Synthesis